Recent research results reached by our group [5] and other labs [6, 7] revealed that Aβ pathology is linked to tau increases in AD [8–11], and rather than Aβ plaques, aberrant neocortical tau aggregations are more strongly associated with neurodegeneration and cognitive decline in AD [5, 6, 12]. The gene discussed is MAPT; the disease is Alzheimer disease.